 |
 |

STROBEA Beacon for Observational Studies
Tamar Nijsten, MD, PhD;
Phyllis Spuls, MD, PhD;
Robert S. Stern, MD
Arch Dermatol. 2008;144(9):1200-1204.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Commentary on: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies von Elm E, Altman DG, Egger M, et al; STROBE Initiative Ann Intern Med. 2007;147(8):573-577 BMJ. 2007;335(7624):806-808 Bull World Health Organ. 2007;85(11):867-872 Epidemiology. 2007;18(6):800-804 Lancet. 2007;370(9596):1453-1457 PLoS Med. 2007;4(10):e296 Prev Med. 2007;45(4):247-251
Question: Which items are important to improve the quality and transparency of observational studies (case-control, cohort, and cross-sectional studies)?
Much biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalizability. The STrengthening the Reporting of OBservational Studies in Epidemiology (STROBE) Initiative developed recommendations on what should be included in an accurate and complete report of an observational study. We defined the scope of the recommendations . . . [Full Text of this Article] Comment
Item 3: Objectives Items 6 and 13: Study Participants Item 7: Variables Item 10: Study Size Item 11: Quantitative Variables Item 12: Statistical Methods AUTHOR INFORMATION
Departments of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands (Dr Nijsten); Amsterdam Medical Center, and the Dutch Cochrane Center, Amsterdam, the Netherlands (Dr Spuls); and Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (Dr Stern)
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|